Manufacturer:
Gilead
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Approved Indication:
treatment of chronic hepatitis C virus in adults and pediatric patients 3 years of age and older with either
- genotype 1, 4, 5, or 6 without cirrhosis or with compensated cirrhosis
- genotype 1 with decompensated cirrhosis in combination with ribavirin
- genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis in combination with ribavirin
Conditions:
- Chronic Viral Hepatitis C
Therapeutic Area:
- Gastroenterology
- Hepatology
- Infectious Disease